BioArctic: New data on lecanemab presented at the 2024 AD/PD™ congress ...Middle East

PR Newswire - News
STOCKHOLM, March 11, 2024 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) and its partner Eisai presented new data on lecanemab (brand name: Leqembi®) at the 2024 International Conference on Alzheimer's and Parkinson's Diseases and related neurological disorders (AD/PD™),...

Hence then, the article about bioarctic new data on lecanemab presented at the 2024 ad pd congress was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( BioArctic: New data on lecanemab presented at the 2024 AD/PD™ congress )

Apple Storegoogle play

Last updated :

Also on site :